is a wholly owned subsidiary of OriGene Technologies, specializing in high
quality, large-scale GMP antibody production in 3 locations in the U.S.; 2
sites in Delaware and one in Maine. For over 25 years, SDIX has been a leading
immuno-solutions company, developing results-oriented and innovative
antibody-based solutions that enable customers, world-wide, to meet high
performance diagnostic and commercialization objectives. All 3 sites are
ISO 13485:2003 certified and the manufacturing site in Delaware is FDA and MHRA
registered for the manufacture and export of class I IHC reagents and
kits. For IHC applications, over 20 CE-marked IVD reagents are
manufactured and sold in the EU and US. Other products include critical
reagents such as antibodies to Troponin I, Strep A, CRP, Apo A1, ApoB,
Micro-albumin and Calibrators. SDIX also provides both polyclonal and
monoclonal antibody development and production services, including long term
supply of monoclonal antibodies for IVD and drug development applications as
well as polyclonal antibody production in goat, rabbit and other species.
In the life science market, SDIX’s technology and capabilities are being used
to help discover disease mechanisms, facilitate development of new drugs, and
provide antibodies and assays utilized in the diagnosis of disease.
Company Description Providence Enterprise is a Hong Kong medical device contract manufacturer of Class I and II medical devices with manufacturing in China & Vietnam. We specialize in electro-mechanical assemblies and high-volume disposables. We ar...